Earnings Ahead

HIMS - Hims & Hers Health, Inc

Hims & Hers Health, Inc

Hims & Hers Health, Inc

About

Profile


Headquarters

San Francisco, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

HIMS

Shares tumbled 22%. While the telehealth provider posted a fourth-quarter earnings and revenue beat, it said it would no longer be able to sell compounded versions of weight loss drugs after the first quarter. This comes after the Food and Drug Administration declared weight loss drugs like Wegovy are no longer in shortage, closing a loophole that allowed Hims & Hers to supply the products.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Him and Hers surges 15% on revenue projections, bottom-line beat
  • Him & Hers Health GAAP EPS of $0.01 beats by $0.03, revenue of $246.62M in-line
  • Him & Hers Health Q4 2023 Earnings Preview
  • Eli Lilly to offer obesity drugs online; hurts Weight Watchers, LifeMD
  • Employers seeking virtual care to manage demand for weight loss drugs: report
  • Hims & Hers stock +6% after hours on raised revenue guidance, $50M share buyback
  • Him & Hers Health GAAP EPS of -$0.04 misses by $0.01, revenue of $226.7M beats by $6.43M
  • Hims & Hers Health announces $50M share repurchase program
  • Him & Hers Health Q3 2023 Earnings Preview
  • Global telemedicine market to hit $450B in 2032: report
  • Biggest stock movers today: Medical Properties Trust, Novavax, Eli Lilly, Tilray Brands, and more
  • Hims & Hers up 13% on Q2 2023 beats, full-year outlook boost
  • Him & Hers Health GAAP EPS of -$0.03 beats by $0.01, revenue of $207.9M beats by $2.94M
  • Him & Hers Health Q2 2023 Earnings Preview
  • Hims & Hers launched Outperform at TD Cowen on valuation
  • Thorne HealthTech gains amid report of sales process
  • Hims & Hers reverses loss, gains amid short call from Spruce Point Research
  • Jefferies taps small- and mid-cap stocks that rank well on all factors
  • Him & Hers Health GAAP EPS of -$0.05 in-line, revenue of $190.78M beats by $11.71M
  • Him & Hers Health Q1 2023 Earnings Preview
Date Price Open High Low Vol Change ER
Sep 14, 2023 6.3 6.47
6.47
6.24
2.5M -0.94%
Sep 13, 2023 6.36 6.45
6.51
6.23
3.2M -1.55%
Sep 12, 2023 6.46 6.5
6.61
6.43
1.9M -1.07%
Sep 11, 2023 6.53 6.57
6.68
6.51
2.0M 0%
Sep 8, 2023 6.53 6.75
6.75
6.52
2.2M -3.4%
 
Sep 7, 2023 6.76 6.79
6.83
6.67
2.0M -2.17%
Sep 6, 2023 6.91 6.9
6.94
6.77
1.3M 0.29%
Sep 5, 2023 6.89 6.81
6.95
6.64
2.3M 0.58%
Sep 1, 2023 6.85 6.84
6.95
6.78
1.6M 2.09%
Aug 31, 2023 6.71 7.01
7.09
6.7
2.3M -3.31%
Aug 30, 2023 6.94 6.94
7.05
6.82
2.1M 0%
Aug 29, 2023 6.94 6.76
7.04
6.68
2.0M 1.31%
Aug 28, 2023 6.85 6.84
7.03
6.8
1.6M 0.59%
Aug 25, 2023 6.81 6.75
6.86
6.59
1.6M 1.49%
Aug 24, 2023 6.71 6.94
6.94
6.64
1.6M -2.61%
Aug 23, 2023 6.89 6.77
6.92
6.73
1.8M 2.23%
Aug 22, 2023 6.74 7.05
7.13
6.7
2.0M -3.71%
Aug 21, 2023 7 6.84
7.04
6.83
2.4M 2.79%
Aug 18, 2023 6.81 6.8
6.95
6.73
3.6M -1.59%
Aug 17, 2023 6.92 6.99
7.1
6.83
3.1M -1.14%
Aug 16, 2023 7 7.18
7.27
6.99
2.0M -2.51%
Aug 15, 2023 7.18 7.03
7.33
7.01
2.5M 0.84%
Aug 14, 2023 7.12 7.16
7.26
6.99
2.7M -1.11%
Aug 11, 2023 7.2 7.14
7.36
7.12
2.4M 0.14%
Aug 10, 2023 7.19 7.38
7.68
7.14
4.8M -1.78%
Aug 9, 2023 7.32 7.41
7.75
7.26
5.4M -1.61%
Aug 8, 2023 7.44 9.26
9.27
7.22
20.2M -5.82%
Aug 7, 2023 7.9 8.33
8.4
7.85
7.1M -3.07%
Aug 4, 2023 8.15 8.2
8.29
8.05
2.7M -0.61%
Aug 3, 2023 8.2 8.32
8.42
8.18
2.6M -2.15%
Aug 2, 2023 8.38 8.56
8.61
8.34
3.2M -4.34%
Aug 1, 2023 8.76 8.84
8.89
8.7
1.7M -2.34%
Jul 31, 2023 8.97 8.65
8.99
8.56
2.8M 3.82%
Jul 28, 2023 8.64 8.62
8.77
8.5
2.1M 2.73%
Jul 27, 2023 8.41 8.41
8.8
8.3
2.4M 1.82%
Jul 26, 2023 8.26 8.23
8.4
8.17
2.7M -0.48%
Jul 25, 2023 8.3 8.32
8.4
8.08
1.9M -0.48%
Jul 24, 2023 8.34 8.29
8.46
8.19
1.8M 0.97%
Jul 21, 2023 8.26 8.43
8.48
8.18
3.6M -1.08%
Jul 20, 2023 8.35 8.84
8.9
8.35
2.2M -6.07%
Jul 19, 2023 8.89 9.17
9.22
8.84
1.9M -2.41%
Jul 18, 2023 9.11 9.21
9.32
9.03
1.7M -0.11%
Jul 17, 2023 9.12 8.77
9.21
8.66
1.9M 2.93%
Jul 14, 2023 8.86 9.08
9.18
8.81
2.6M -2.74%
Jul 13, 2023 9.11 8.54
9.27
8.44
5.6M 5.07%
Jul 12, 2023 8.67 8.83
8.92
8.63
5.0M 0.35%
Jul 11, 2023 8.64 8.68
8.77
8.48
2.7M 0.35%
Jul 10, 2023 8.61 8.3
8.63
8.26
3.6M 4.11%
Jul 7, 2023 8.27 8.68
8.75
8.23
3.4M -4.39%
Jul 6, 2023 8.65 8.82
8.86
8.59
1.6M -2.7%
Jul 5, 2023 8.89 9.09
9.15
8.69
3.1M -2.41%
Jul 3, 2023 9.11 9.43
9.46
9.08
2.3M -3.09%
Jun 30, 2023 9.4 9.17
9.61
9.09
3.8M 3.41%
Jun 29, 2023 9.09 8.56
9.16
8.54
4.1M 7.32%
Jun 28, 2023 8.47 8.3
8.5
8.25
1.3M 1.68%
Jun 27, 2023 8.33 8.28
8.52
8.19
2.0M 1.34%
Jun 26, 2023 8.22 8.32
8.47
8.17
2.4M -2.38%
Jun 23, 2023 8.42 8.25
8.42
8.17
5.0M 0.96%
Jun 22, 2023 8.34 8.45
8.56
8.28
2.1M -0.95%
Jun 21, 2023 8.42 8.37
8.49
8.3
2.4M 0%